Journal of Obesity & Metabolic Syndrome

Search

Article

Korean J Obes 2011; 20(2): 84-90

Published online June 1, 2011

Copyright © Korean Society for the Study of Obesity.

Associations of Serum Vascular Endothelial Growth Factor and Abdominal Fat Distributions in Obese Korean Women

Kyung Eun Yun*, Hye Soon Park(1), Chan Keum Park(2), Young Sook Song(2), Yeon Jin Jang(2)

Health Screening Center, Kangbuk Samsung Hospital, Sungkyunkwan University, School of Medicine; Department of Family Medicine, University of Ulsan College of Medicine(1), Department of Physiology, University of Ulsan College of Medicine(2)

Background: Vascular endothelial growth factor (VEGF) is a very potent angiogenic factor expressed and secreted from adipocytes, and VEGF-mediated angiogenesis is necessary for the adipose tissue expansion associated with human obesity. This study investigates the associations of serum VEGF concentration and abdominal fat distributions in obese Korean women.
Methods: A cross-sectional study was conducted in 37 obese women (BMI ≥ 30 kg/m2) who visited the obesity clinic in a tertiary health care center (Seoul, Korea). Anthropometric indices were measured and abdominal fat distribution was assessed by computed tomography. Fasting plasma glucose, insulin, lipid profiles, and serum VEGF concentrations were measured.
Results: Serum VEGF concentration significantly correlated with BMI (r = 0.478, P = 0.024) and visceral fat area (r = 0.449, P = 0.036) after adjustment for age. In multivariate linear regression analysis, visceral fat area was independently associated with serum VEGF concentration in the study subjects.
Conclusion: The present study shows that visceral fat accumulation is independently associated with elevation of serum VEGF concentrations in obese Korean women. This suggests the intriguing possibility that anti-angiogenic components may reduce visceral fat in obese subjects.

Keywords: VEGF, BMI, Visceral fat accumulation, Obesity


Basic characteristics of the study participants



Correlations between serum VEGF concentration, anthropometric measirements, and cardiometabolic risk factors in the study participants



Multiple regression analysis for the relationship between serum VEGF concentration with anthropometric measurements and cardiometabolic risk factors


  1. Matsuzawa Y. Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease. Nat Clin Pract Cardiovasc Med 2006;3(1):35-42.
    Pubmed CrossRef
  2. Guerre-Millo M. Adipose tissue and adipokines: for better or worse. Diabetes Metab 2004;30(1):13-9.
    CrossRef
  3. Cao Y. Angiogenesis modulates adipogenesis and obesity. J Clin Invest 2007;117(9):2362-8.
    Pubmed KoreaMed CrossRef
  4. Nishimura S, Manabe I, Nagasaki M, Hosoya Y, Yamashita H, Fujita H, et al. Adipogenesis in obesity requires close interplay between differentiating adipocytes, stromal cells, blood vessels. Diabetes 2007;56(6):1517-26.
    Pubmed CrossRef
  5. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989;246(4935):1306-9.
    Pubmed CrossRef
  6. Miyazawa-Hoshimoto S, Takahashi K, Bujo H, Hashimoto N, Yagui K, Saito Y. Roles of degree of fat deposition and its localization on VEGF expression in adipocytes. Am J Physiol Endocrinol Metab 2005;288(6):E1128-36.
    Pubmed CrossRef
  7. Zhang QX, Magovern CJ, Mack CA, Budenbender KT, Ko W, Rosengart TK. Vascular endothelial growth factor is the major angiogenic factor in omentum: mechanism of the omentum-mediated angiogenesis. J Surg Res 1997;67(2):147-54.
    Pubmed CrossRef
  8. Ledoux S, Queguiner I, Msika S, Calderari S, Rufat P, Gasc JM, et al. Angiogenesis associated with visceral and subcutaneous adipose tissue in severe human obesity. Diabetes 2008;57(12):3247-57.
    Pubmed KoreaMed CrossRef
  9. Schiekofer S, Galasso G, Sato K, Kraus BJ, Walsh K. Impaired revascularization in a mouse model of type 2 diabetes is associated with dysregulation of a complex angiogenic-regulatory network. Arterioscler Thromb Vasc Biol 2005;25(8):1603-9.
    Pubmed CrossRef
  10. Chou E, Suzuma I, Way KJ, Opland D, Clermont AC, Naruse K, et al. Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic States: a possible explanation for impaired collateral formation in cardiac tissue. Circulation 2002;105(3):373-9.
    Pubmed CrossRef
  11. Silha JV, Krsek M, Sucharda P, Murphy LJ. Angiogenic factors are elevated in overweight and obese individuals. Int J Obes 2005;29(11):1308-14.
    Pubmed CrossRef
  12. Miyazawa-Hoshimoto S, Takahashi K, Bujo H, Hashimoto N, Saito Y. Elevated serum vascular endothelial growth factor is associated with visceral fat accumulation in human obese subjects. Diabetologia 2003;46(11):1483-8.
    Pubmed CrossRef
  13. Seida A, Wada J, Kunitomi M, Tsuchiyama Y, Miyatake N, Fujii M, et al. Serum bFGF levels are reduced in Japanese overweight men and restored by a 6-month exercise education. Int J Obes Relat Metab Disord 2003;27(11):1325-31.
    Pubmed CrossRef
  14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28(7):412-9.
    Pubmed CrossRef
  15. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004;145(5):2273-82.
    Pubmed CrossRef
  16. Nishimura S, Manabe I, Nagasaki M, Hosoya Y, Yamashita H, Fujita H, et al. Adipogenesis in obesity requires close interplay between differentiating adipocytes, stromal cells, blood vessels. Diabetes 2007;56(6):1517-26.
    Pubmed CrossRef
  17. Silverman KJ, Lund DP, Zetter BR, Lainey LL, Shahood JA, Freiman DG, et al. Angiogenic activity of adipose tissue. Biochem Biophys Res Commun 1988;153(1):347-52.
    CrossRef
  18. Goldsmith HS, Griffith AL, Kupferman A, Catsimpoolas N. Lipid angiogenic factor from omentum. JAMA 1984;252(15):2034-6.
    Pubmed CrossRef
  19. Li B, Zeng Q, Wang H, Shao S, Mao X, Zhang F, et al. Adipose tissue stromal cells transplantation in rats of acute myocardial infarction. Coron Artery Dis 2007;18(3):221-7.
    Pubmed CrossRef
  20. Rehman J, Traktuev D, Li J, Merfeld-Clauss S, Temm-Grove CJ, Bovenkerk JE, et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 2004;109(10):1292-8.
    Pubmed CrossRef
  21. Fukumura D, Ushiyama A, Duda DG, Xu L, Tam J, Krishna V, et al. Paracrine regulation of angiogenesis and adipocyte differentiation during in vivo adipogenesis. Circ Res 2003;93(9):e88-97.
    Pubmed KoreaMed CrossRef
  22. Rupnick MA, Panigrahy D, Zhang CY, Dallabrida SM, Lowell BB, Langer R, et al. Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci U S A 2002;99(16):10730-5.
    Pubmed KoreaMed CrossRef
  23. Garcia de la Torre N, Rubio MA, Bordiu E, Cabrerizo L, Aparicio E, Hernandez C, et al. Effects of weight loss after bariatric surgery for morbid obesity on vascular endothelial growth factor-A, adipocytokines, insulin. J Clin Endocrinol Metab 2008;93(11):4276-81.
    Pubmed CrossRef
  24. Wada H, Satoh N, Kitaoka S, Ono K, Morimoto T, Kawamura T, et al. Soluble VEGF receptor-2 is increased in sera of subjects with metabolic syndrome in association with insulin resistance. Atherosclerosis 2010;208(2):512-7.
    Pubmed CrossRef